Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1

Conditions

Lung Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Glioma 2 Glioblastoma 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Ductal Adenocarcinoma 1 Osteoradionecrosis 1 Mouth Neoplasms 1 Melanoma 1 Hereditary leiomyomatosis and renal cell cancer 1 Hematopoietic and Lymphoid System Neoplasm 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Fallopian Tube Mucinous Adenocarcinoma 1 Ependymoma 1 Craniopharyngioma 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

pembrolizumab 137 Nivolumab 116 Ipilimumab 68 Cyclophosphamide 33 Specimen Handling 31 Magnetic Resonance Spectroscopy 28 trametinib 23 binimetinib 22 fludarabine 21 Interleukin-2 20 dabrafenib 19 relatlimab 17 encorafenib 17 Biopsy 17 CTLA-4 Antigen 16 cemiplimab 15 atezolizumab 15 aldesleukin 15 Radiosurgery 15 fludarabine phosphate 14 Opdualag 14 Radiotherapy 11 lenvatinib 10 Blood Specimen Collection 10 lifileucel 9 Paclitaxel 8 Cisplatin 8 Bevacizumab 8 spartalizumab 7 cobimetinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Contrast Media × 1 year × Clear all

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡